Surprisingly, the heterozygous deficiency of PHD2 led to improved endothelial lining, vessel maturation, tumor perfusion and oxygenation with a subsequent inhibition of tumor cell invasion, intravasation and metastasis. The gene discussed is EGLN1; the disease is neoplasm.